Moreover, the overexpression of PKM2 in various cancers, its link to tumor proliferation and metastasis, and its regulatory interactions within the tumor microenvironment and with lncRNAs underscore the enzyme’s complexity and potential as both a diagnostic marker and therapeutic target [49,50]. This evidence concerns the gene PKM and cancer.